116 related articles for article (PubMed ID: 8947337)
1. Mediator release is altered in immunotherapy-treated patients: a 4-year study.
Dokic D; Nethe A; Kleine-Tebbe J; Kunkel G; Baumgarten CR
Allergy; 1996 Nov; 51(11):796-803. PubMed ID: 8947337
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of allergen sensitivity early in the course of ragweed immunotherapy.
Hedlin G; Silber G; Schieken L; Naclerio R; Proud D; Eggleston P; Adkinson NF
J Allergy Clin Immunol; 1989 Sep; 84(3):390-9. PubMed ID: 2476472
[TBL] [Abstract][Full Text] [Related]
3. A double-blind study of the discontinuation of ragweed immunotherapy.
Naclerio RM; Proud D; Moylan B; Balcer S; Freidhoff L; Kagey-Sobotka A; Lichtenstein LM; Creticos PS; Hamilton RG; Norman PS
J Allergy Clin Immunol; 1997 Sep; 100(3):293-300. PubMed ID: 9314339
[TBL] [Abstract][Full Text] [Related]
4. Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy.
Creticos PS; Adkinson NF; Kagey-Sobotka A; Proud D; Meier HL; Naclerio RM; Lichtenstein LM; Norman PS
J Clin Invest; 1985 Dec; 76(6):2247-53. PubMed ID: 2416777
[TBL] [Abstract][Full Text] [Related]
5. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
[TBL] [Abstract][Full Text] [Related]
6. Responses to ragweed-pollen nasal challenge before and after immunotherapy.
Creticos PS; Marsh DG; Proud D; Kagey-Sobotka A; Adkinson NF; Friedhoff L; Naclerio RM; Lichtenstein LM; Norman PS
J Allergy Clin Immunol; 1989 Aug; 84(2):197-205. PubMed ID: 2668381
[TBL] [Abstract][Full Text] [Related]
7. Allergen-specific immunotherapy in birch- and grass-pollen-allergic rhinitis. II. Side-effects.
Winther L; Malling HJ; Mosbech H
Allergy; 2000 Sep; 55(9):827-35. PubMed ID: 11003446
[TBL] [Abstract][Full Text] [Related]
8. Short-term immunotherapy: a prospective, randomized, double-blind, placebo-controlled multicenter study of molecular standardized grass and rye allergens in patients with grass pollen-induced allergic rhinitis.
Zenner HP; Baumgarten C; Rasp G; Fuchs T; Kunkel G; Hauswald B; Ring J; Effendy I; Behrendt W; Frosch PJ; Przybilla B; Brunner FX; Merk HF; Kapp A; Schnitker J; Wolf H
J Allergy Clin Immunol; 1997 Jul; 100(1):23-9. PubMed ID: 9257783
[TBL] [Abstract][Full Text] [Related]
9. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. IV. Comparison of the safety and efficacy of two dosages of a high-molecular-weight allergoid.
Bousquet J; Hejjaoui A; Soussana M; Michel FB
J Allergy Clin Immunol; 1990 Feb; 85(2):490-7. PubMed ID: 2406327
[TBL] [Abstract][Full Text] [Related]
10. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. II. Comparison between parameters assessing the efficacy of immunotherapy.
Bousquet J; Maasch H; Martinot B; Hejjaoui A; Wahl R; Michel FB
J Allergy Clin Immunol; 1988 Sep; 82(3 Pt 1):439-46. PubMed ID: 3170992
[TBL] [Abstract][Full Text] [Related]
11. The nasal response to histamine challenge: effect of the pollen season and immunotherapy.
Majchel AM; Proud D; Freidhoff L; Creticos PS; Norman PS; Naclerio RM
J Allergy Clin Immunol; 1992 Jul; 90(1):85-91. PubMed ID: 1629510
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the in-vivo and in-vitro response to ragweed immunotherapy in children and adults with ragweed-induced rhinitis.
Hedlin G; Silber G; Naclerio R; Proud D; Lamas AM; Eggleston P; Adkinson NF
Clin Exp Allergy; 1990 Sep; 20(5):491-500. PubMed ID: 2253080
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study.
Bufe A; Ziegler-Kirbach E; Stoeckmann E; Heidemann P; Gehlhar K; Holland-Letz T; Braun W
Allergy; 2004 May; 59(5):498-504. PubMed ID: 15080830
[TBL] [Abstract][Full Text] [Related]
14. Differences in clinical and immunologic reactivity of patients allergic to grass pollens and to multiple-pollen species. II. Efficacy of a double-blind, placebo-controlled, specific immunotherapy with standardized extracts.
Bousquet J; Becker WM; Hejjaoui A; Chanal I; Lebel B; Dhivert H; Michel FB
J Allergy Clin Immunol; 1991 Jul; 88(1):43-53. PubMed ID: 2071784
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy with alginate-conjugated two grass pollen extract in patients with allergic rhinoconjunctivitis.
Tari MG; Mancino M; Pozzuoli G; Mauro B; Verga A; Monti G
Allergol Immunopathol (Madr); 1990; 18(1):35-40. PubMed ID: 2382596
[TBL] [Abstract][Full Text] [Related]
16. Mediator release after allergic and physical nasal challenges.
Norman PS; Naclerio RM; Creticos PS; Togias A; Lichtenstein LM
Int Arch Allergy Appl Immunol; 1985; 77(1-2):57-63. PubMed ID: 2409027
[TBL] [Abstract][Full Text] [Related]
17. Nasal challenge with pollen grains, skin-prick tests and specific IgE in patients with grass pollen allergy.
Bousquet J; Lebel B; Dhivert H; Bataille Y; Martinot B; Michel FB
Clin Allergy; 1987 Nov; 17(6):529-36. PubMed ID: 3436032
[TBL] [Abstract][Full Text] [Related]
18. Diminished response to grass pollen allergen challenge in subjects with concurrent house dust mite allergy.
Reinartz SM; van Ree R; Versteeg SA; Zuidmeer L; van Drunen CM; Fokkens WJ
Rhinology; 2009 Jun; 47(2):192-8. PubMed ID: 19593978
[TBL] [Abstract][Full Text] [Related]
19. Local nasal immunotherapy with extract in powder form is effective and safe in grass pollen rhinitis: a double-blind study.
Andri L; Senna G; Betteli C; Givanni S; Andri G; Dimitri G; Falagiani P; Mezzelani P
J Allergy Clin Immunol; 1996 Jan; 97(1 Pt 1):34-41. PubMed ID: 8568135
[TBL] [Abstract][Full Text] [Related]
20. Nasal immunotherapy in pollen-sensitive children.
Cserháti E; Mezei G
Allergy; 1997; 52(33 Suppl):40-4. PubMed ID: 9188948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
